PetMeds® To Announce Its Fourth Quarter Financial Results On May 9, 2022
PetMed Express, Inc. (NASDAQ: PETS) will report its financial results for the fiscal year and fourth quarter ending March 31, 2022, on May 9, 2022, at 4:00 P.M. Eastern Time. A conference call will follow at 4:30 P.M. to discuss the results. Interested parties can access the call by dialing (800) 891-8256 or through a webcast link provided in the release. The replay will be available after the event until May 23, 2022. PetMed Express specializes in delivering pet medications and health products to consumers across the USA.
- None.
- None.
DELRAY BEACH, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for the quarter and year ended March 31, 2022, on Monday, May 9, 2022, at 4:00 P.M. Eastern Time, then at 4:30 P.M. Eastern Time, the Company will host a conference call to review the financial results.
To access the call, which is open to the public, please dial (800) 891-8256 (toll free) or (415) 226-5361, ten minutes prior to the scheduled start time, and all callers will be placed on hold until the call begins at 4:30 P.M Eastern Time. We will also provide a link at https://www.1800petmeds.com/investor.htmlpetmeds.com/investor.html for those who wish to stream the call via webcast.
For those unable to participate in the live event, the call will be available for replay from 7:30 P.M. Eastern Time on May 9, 2022, until May 23, 2022, at 11:59 P.M. Eastern Time. To access the replay, call (844) 512-2921 (toll free) or (412) 317-6671 and enter passcode 22018680.
Founded in 1996, PetMeds is Your Trusted Pet Health Expert and America’s Most Trusted Pet Pharmacy®, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at www.petmeds.com.
This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2021. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.
For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 561-526-4444, investor@petmeds.com.
For media relations contact Butin PR, Mary Eva Tredway, maryeva@butinpr.com.
FAQ
When will PetMed Express announce its financial results for the quarter ended March 31, 2022?
What time is the conference call for PetMed Express's financial results?
How can I access the PetMed Express conference call?